Content area

Details

Title
1082; Safety, Tolerability, and Immunogenicity of an Investigational Meningococcal Serogroup B Bivalent rLP2086 Vaccine in Healthy Adolescents Aged 11 to 18 Years in Three Phase 2, Randomized, Controlled Studies
Author
Vesikari, Timo 1 ; Beeslaar, Johannes 2 ; Eiden, Joseph 3 ; Jiang, Qin 2 ; Harris, Shannon 2 ; York, Laura J 2 ; Morgenstern, Diana 2 ; Bhuyan, Prakash 2 ; Perez, John L 2 

1  University of Tampere Medical School, Tampere, Finland 
2  Pfizer Vaccine Research, Collegeville, PA 
3  Pfizer Vaccine Research, Pearl River, NY 
Pages
S318-S318
Publication year
2014
Publication date
Fall 2014
Publisher
Oxford University Press
e-ISSN
23288957
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1093/ofid/ofu052.790
ProQuest document ID
3170981064
Copyright
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America.